7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amine CAS 937046-98-5 Remdesivir Intermediate COVID-19
Produsen Pasokan Komersial Remdesivir lan Intermediet sing Gegandhengan kanthi Kualitas Tinggi
Remdesivir CAS 1809249-37-3
2-Etil-1-butanol CAS 97-95-0
Trimetilsilil Sianida CAS 7677-24-9
4-Nitrophenol CAS 100-02-7
2-Etilbutil ((S)-(perfluorofenoksi)(fenoksi)fosforil)-L-alaninate CAS 1911578-98-7
N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-etilbutil ester CAS 1354823-36-1
(S)-2-Etilbutil 2-Aminopropanoate Hydrochloride CAS 946511-97-3
Metabolit Remdesivir (GS-441524) CAS 1191237-69-0
Remdesivir N-2 Intermediate CAS 1191237-80-5
2,3,5-Tri-O-benzyl-D-ribonolactone CAS 55094-52-5
7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amin CAS 937046-98-5
Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine CAS 159326-68-8
4-Amino-7-iodopyrrolo[2,1-f][1,2,4]triazine CAS 1770840-43-1
Jeneng Kimia | 7-Bromopyrrolo[2,1-f][1,2,4]triazin-4-amin |
sinonim | 4-Amino-7-bromopyrrolo [2,1-f] [1,2,4] triazine;Remdesivir Impurity 2 |
Nomer CAS | 937046-98-5 |
Nomer CAT | RF-PI305 |
Status Simpenan | Ing Stok, Skala Produksi Nganti Atusan Kilogram |
Formula Molekul | C6H5BrN4 |
Bobot Molekul | 213.04 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Kuning Muda |
Spektrum Infrared | Conforms kanggo Struktur |
NMR | Conforms kanggo Struktur |
Kemurnian | ≥97,0% |
Mundhut ing Pangatusan | ≤1.0 |
Impurity Tunggal | ≤1,0% |
Logam abot | ≤20ppm |
Test Standar | Standar Perusahaan |
Panggunaan | Perantara Remdesivir (CAS 1809249-37-3) |
Paket: Botol, tas Aluminium foil, Drum karton, 25kg / Drum, utawa miturut kabutuhan pelanggan.
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya, kelembapan lan infestasi hama.
7-Bromopyrrolo [2,1-f] [1,2,4] triazin-4-amine (CAS 937046-98-5) minangka Intermediate Remdesivir (CAS 1809249-37-3).Remdesivir minangka obat antivirus kanthi aktivitas nglawan sindrom pernapasan akut parah coronavirus 2 (SARS-CoV-2).Remdesivir (uga dikenal minangka Veklury utawa GS-5734) minangka inhibitor polimerase RNA analog nukleotida SARS-CoV-2 sing dituduhake kanggo wong diwasa lan pasien bocah (umur 12 taun lan luwih lawas lan bobote paling ora 40 kg) kanggo perawatan penyakit koronavirus 2019. (COVID-19) mbutuhake rawat inap.Remdesivir mung kudu diwenehake ing rumah sakit utawa ing setelan kesehatan sing bisa menehi perawatan akut sing bisa dibandhingake karo perawatan rumah sakit rawat inap.Remdesivir wiwitane dikembangake minangka anti-virus nglawan virus Ebola, nanging wiwit wis ditampilake nyuda beban virus saka sawetara virus RNA kalebu virus respiratory syncytial (RSV) lan β-coronavirus kayata SARS-CoV, MERS-CoV, lan agen penyebab COVID-19, SARS-CoV-2.